Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Medical device-maker AtriCure Inc. (NSDQ:ATRC) could be poised for a buyout over the next year to 18 months, according to Canaccord Genuity analyst Jason Mills.
Hologic (NSDQ:HOLX) shares are down more than 3 percent this morning after a decision by an affiliate of health insurer Wellpoint that its Selenia Dimensions 3D mammography system is "investigational and not medically necessary."
MassDevice looks back at the two memorable years J. Raymond Elliot spent in the corner office at med-tech goliath Boston Scientific (NYSE:BSX). Elliot stepped down today, passing the torch to interim CEO Hank Kucheman.